An inverse association of CREB or MEF2D activation with GFAP expression has been previously described in models of Alzheimer disease 73 or isoflurane neuroprotection in ischemia/reperfusion 74. Here, MEF2D is linked to early-onset autosomal dominant Alzheimer disease.